
Genflow Biosciences plc (GENF.L)
GENF.L Stock Price Chart
Explore Genflow Biosciences plc interactive price chart. Choose custom timeframes to analyze GENF.L price movements and trends.
GENF.L Company Profile
Discover essential business fundamentals and corporate details for Genflow Biosciences plc (GENF.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Jan 2022
Employees
5.00
Website
https://genflowbio.comCEO
Eric Jean Leire MBA
Description
Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.
GENF.L Financial Timeline
Browse a chronological timeline of Genflow Biosciences plc corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 1 May 2025
Earnings released on 7 May 2024
Earnings released on 7 May 2024
EPS came in at -£0.00, while revenue for the quarter reached -£97.03K.
Earnings released on 29 Sept 2023
EPS came in at -£0.00, while revenue for the quarter reached -£97.03K.
Earnings released on 30 Jun 2023
EPS came in at -£0.00, while revenue for the quarter reached £97.03K.
Earnings released on 31 Mar 2023
EPS came in at -£0.00, while revenue for the quarter reached £97.03K.
Earnings released on 31 Dec 2022
EPS came in at -£0.00.
Earnings released on 30 Sept 2022
EPS came in at -£0.00.
Earnings released on 30 Jun 2022
EPS came in at -£0.00.
Earnings released on 31 Mar 2022
EPS came in at -£0.00.
Earnings released on 30 Jun 2021
EPS came in at -£0.00.
Earnings released on 31 Mar 2021
EPS came in at -£0.00.
GENF.L Stock Performance
Access detailed GENF.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.